CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 37 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-01-28 | KESTEN STEVEN Exec VP and Chief MO | Grant or award | +47,000 | 49,201 | ||
| 2016-01-28 | Girao Tiago VP & Chief Financial Officer | Grant or award | +35,250 | 123,250 | ||
| 2016-01-28 | HEDRICK MARC H President and CEO | Grant or award | +70,500 | 575,111 | ||
| 2016-01-04 | HAWRAN PAUL W Director | Grant or award · Incentive Stock Option (Right to Buy) | +53,820 | 245,950 | ||
| 2016-01-04 | Hawkins Richard J Director | Grant or award · Incentive Stock Option (Right to Buy) | +53,820 | 220,950 | ||
| 2016-01-04 | RICKEY DAVID Director | Grant or award · Incentive Stock Option (Right to Buy) | +53,820 | 245,950 | ||
| 2016-01-04 | Thompson Tommy G Director | Grant or award · Incentive Stock Option (Right to Buy) | +53,820 | 136,950 | ||
| 2016-01-04 | Naughton Gail K Director | Grant or award · Incentive Stock Option (Right to Buy) | +53,820 | 99,820 | ||
| 2016-01-04 | LYONS GARY A Director | Grant or award · Incentive Stock Option (Right to Buy) | +53,820 | 99,820 | ||
| 2016-01-04 | HAYDEN JEREMY B. General Counsel & VP of BD | Grant or award · Employee Stock Option | +255,645 | 455,645 | ||
| 2016-01-04 | Girao Tiago VP & Chief Financial Officer | Grant or award · Employee Stock Option | +349,830 | 619,830 | ||
| 2016-01-04 | HARRIS JOHN DAVID VP and GM Cell Therapy | Grant or award · Employee Stock Option | +349,830 | 684,830 | ||
| 2016-01-04 | KESTEN STEVEN Exec VP and Chief MO | Grant or award · Employee Stock Option | +699,660 | 1,240,660 | ||
| 2016-01-04 | HEDRICK MARC H President and CEO | Grant or award · Employee Stock Option | +834,210 | 2,269,210 | ||
| 2015-11-11 | HARRIS JOHN DAVID VP and GM Cell Therapy | Grant or award · Stock Option (Right to Buy) | +335,000 | 335,000 | ||
| 2015-09-03 | Thompson Tommy G Director | Purchase | +25,449 | $0.37 | $10K | 83,600 |
| 2015-09-02 | HAYDEN JEREMY B. General Counsel & VP of BD | Purchase | +8,200 | $0.36 | $3K | 26,200 |
| 2015-08-28 | RICKEY DAVID Director | Purchase | +35,000 | $0.31 | $11K | 220,059 |
| 2015-08-28 | RICKEY DAVID Director | Purchase | +21,000 | $0.31 | $7K | 653,385 |
| 2015-08-28 | HEDRICK MARC H President and CEO | Purchase | +1,200 | $0.31 | $372 | 44,800 |
Page 16 of 53 · 1,048 trades